• OPEN AN ACCOUNT
Indian Indices
Nifty
26,053.90 117.70
(0.45%)
Sensex
84,997.13 368.97
( 0.44%)
Bank Nifty
58,385.25 171.15
( 0.29%)
Nifty IT
36,090.10 229.70
( 0.64%)
Global Indices
Nasdaq
47,736.03 170.44
(0.36%)
Dow Jones
6,915.96 19.80
(0.29%)
Hang Seng
51,290.81 1,071.63
(2.13%)
Nikkei 225
9,704.22 50.40
(0.52%)
Forex
USD-INR
88.12 0.31
(0.36%)
EUR-INR
102.54 0.45
(0.44%)
GBP-INR
117.47 0.63
(0.54%)
JPY-INR
0.58 0.00
(0.35%)

EQUITY - MARKET SCREENER

Novartis India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500672
INE234A01025
317.91821
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NOVARTIND
20.74
2132.05
EPS(TTM)
Face Value()
Div & Yield %
41.63
5
2.89
 

novartis india ltd
Novartis India Ltd - Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter Ended September 30 2025.
Sep 30,2025
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 inter alia to consider and approve The Meeting of the Board of Directors of Novartis India Limited is scheduled to be held on Tuesday October 28 2025 to inter alia consider the Unaudited Financial Results for the half year and quarter ended September 30 2025.